inspra and Kaon Interactions

Interactions between inspra(eplerenone) and Kaon (potassium gluconate)

potassium gluconate and eplerenone (Major Drug-Drug)

CONTRAINDICATED: The principal risk of eplerenone is hyperkalemia. Coadministration with potassium salts or potassium-sparing diuretics may increase this risk due to additive pharmacodynamic effects.

MANAGEMENT: Given the potential for serious, sometimes fatal cardiac arrhythmias associated with hyperkalemia, the use of eplerenone with potassium salts or potassium-sparing diuretics is considered contraindicated.